Home > Cashflow Statement > AJANTA PHARMA

AJANTA PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-733 Cr₹-1,051 Cr₹-108 Cr₹-460 Cr₹-318 Cr

What is the latest Cash Flow from Financing Activities ratio of AJANTA PHARMA ?

The latest Cash Flow from Financing Activities ratio of AJANTA PHARMA is ₹-733 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-733 Cr
Mar2024₹-1,051 Cr
Mar2023₹-108 Cr
Mar2022₹-460 Cr
Mar2021₹-318 Cr

How is Cash Flow from Financing Activities of AJANTA PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-733 Cr
Negative
Mar2024 ₹-1,051 Cr
Negative
Mar2023 ₹-108 Cr
Negative
Mar2022 ₹-460 Cr
Negative
Mar2021 ₹-318 Cr -

Compare Cash Flow from Financing Activities of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹39,319.8 Cr -0.8% 12.6% 22.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹453,750.0 Cr 0.6% 13.6% 8.4% Stock Analytics
DIVIS LABORATORIES ₹182,117.0 Cr 1.5% 9.1% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,314.0 Cr 1.5% 8.2% 35.7% Stock Analytics
CIPLA ₹113,225.0 Cr -2.1% 13.7% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,037.0 Cr -1.4% 8% 7.4% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-0.8%

12.6%

22.6%

SENSEX

-0.3%

-4.3%

-8.9%


You may also like the below Video Courses